Related Experiment Video
Updated: Jul 1, 2025

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
Published on: April 21, 2022
[Characterization of otorhinolaryngologic manifestations in children with mucopolysaccharide storage disease typeⅠand
Xinru Bai1,2, Rong Liu2, Shunqiao Feng2
1Graduate School of Peking Union Medical College,Beijing,100730,Chian.
Insights
Otorhinolaryngologic symptoms, including airway obstruction and hearing loss, are common in children with Mucopolysaccharidoses (MPS) types I and II, often appearing before diagnosis. Early recognition by specialists improves patient outcomes.
Area of Science:
- Pediatrics
- Genetics
- Otorhinolaryngology
Abstract:
Objective:To analyze the characteristics of otorhinolaryngological clinical manifestations in children with Mucopolysaccharide(MPS) type Ⅰ and type II in order to improve the knowledge of otorhinolaryngologists about this disease. Methods:Clinical data related to 55 children with MPS type Ⅰ and type II were retrospectively analyzed to investigate the clinical manifestations of MPS in ENT. Results:All 40 patients(72.72%) with MPS had at least one ENT symptom during the course of the disease, with 95% of them having an ENT symptom prior to the diagnosis of MPS; upper airway obstruction was the most common ENT symptom(34, 85.00%), followed by recurrent upper respiratory tract infections(23, 57.50%), and lastly, hearing loss(11, 27.50%); all 26 patients had undergone at least one surgical procedure, of which 15(57.69%) had undergone ENT surgery, and all of these patients underwent ENT surgery before diagnosis. The most common ENT surgery was adenoidectomy. Conclusion:Early clinical manifestations of MPS patients are atypical, but the early and prevalent appearance of otolaryngologic symptoms and increased awareness of the disease among otolaryngologists has a positive impact on the prognosis of MPS.
Related Concept Videos
Lysosomal Hydrolases
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Proteoglycans
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

